Dear Editors, We read the article “Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis” comparing ilunocitinib to oclacitinib for control of pruritus, measured by owner-assessed pruritus Visual Analog Scale (PVAS), and skin lesions, measured by Canine Atopic Dermatitis Extent and Severity Index, 4th iteration (CADESI-04) [1].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Michal
Contact Michal, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack